Medical team and oversight Named clinicians should appear only if public and accurate
It is important to note that while Ozempic has demonstrated cardiovascular benefits in clinical trials, it is specifically licensed for blood glucose management in type 2 diabetes, not for cardiovascular risk reduction
Psychosocial care for people with diabetes: a position statement of the American Diabetes Association
Haymaker C, Federico L, Forget MA, Vence LM, Sharma P, Allison JP, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba I, Sepesi B, Heymach J, Gibbons D, Bernatchez C, Weissferdt A, Vaporciyan AA, Futreal A, Karpinets T, Yee C, Lizee G, Talukder A, Roszik J, Tran H, Vasquez M, Prado E, Behrens C, Parra E, Rodriguez-Canales J, Fujimoto J, Roth J, Meraz I, Roarty E, Landry L, Byers L, Kalhor N, Swisher SG , William Jr W
The purpose of this article is to provide a comprehensive, medically grounded exploration of how Ozempic and similar GLP-1 medications may influence IBS symptoms